Cargando…

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

Stockpiling of pre-pandemic influenza vaccines guarantees immediate vaccine availability to counteract an emerging pandemic. Generally, influenza vaccines need to be stored and handled refrigerated to prevent thermal degradation of the antigenic component. Requirement of a cold-chain, however, compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geeraedts, Felix, Saluja, Vinay, ter Veer, Wouter, Amorij, Jean-Pierre, Frijlink, Henderik W., Wilschut, Jan, Hinrichs, Wouter L. J., Huckriede, Anke
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844510/ https://www.ncbi.nlm.nih.gov/pubmed/20195930 http://dx.doi.org/10.1208/s12248-010-9179-z

Ejemplares similares

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
por: Geeraedts, Felix, et al.
Publicado: (2008)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
por: Heida, Rick, et al.
Publicado: (2023)

Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro
por: Heida, Rick, et al.
Publicado: (2022)

The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production
por: Kanojia, Gaurav, et al.
Publicado: (2016)

Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling
por: Geeraedts, Felix, et al.
Publicado: (2008)

A User-Friendly Model for Spray Drying to Aid Pharmaceutical Product Development
por: Grasmeijer, Niels, et al.
Publicado: (2013)

Stability of Lysozyme in Aqueous Extremolyte Solutions during Heat Shock and Accelerated Thermal Conditions
por: Avanti, Christina, et al.
Publicado: (2014)

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus
por: Bhide, Yoshita, et al.
Publicado: (2018)

Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
por: Patil, Harshad P., et al.
Publicado: (2017)

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice
por: van der Kooij, Renée S., et al.
Publicado: (2023)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
por: Heida, Rick, et al.
Publicado: (2021)

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine
por: Tian, Yu, et al.
Publicado: (2020)

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine
por: Sibum, Imco, et al.
Publicado: (2019)

Developments in the formulation and delivery of spray dried vaccines
por: Kanojia, Gaurav, et al.
Publicado: (2017)

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023)

Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
por: de Waard, Hans, et al.
Publicado: (2010)

Controlled Crystallization of the Lipophilic Drug Fenofibrate During Freeze-Drying: Elucidation of the Mechanism by In-Line Raman Spectroscopy
por: de Waard, Hans, et al.
Publicado: (2010)

Prerequisites for a dry powder inhaler for children with cystic fibrosis
por: Lexmond, Anne J., et al.
Publicado: (2017)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

A New Strategy to Stabilize Oxytocin in Aqueous Solutions: I. The Effects of Divalent Metal Ions and Citrate Buffer
por: Avanti, Christina, et al.
Publicado: (2011)

Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings
por: Nguyen, Khanh T. T., et al.
Publicado: (2023)

Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review
por: Nugrahadi, Primawan Putra, et al.
Publicado: (2023)

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(®) High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
por: Sibum, Imco, et al.
Publicado: (2020)

Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen
por: van der Kooij, Renée S., et al.
Publicado: (2021)

Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions
por: Ruigrok, Mitchel J.R., et al.
Publicado: (2021)

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial
por: van Doorn, Eva, et al.
Publicado: (2017)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Targeting the small airways with dry powder adenosine: a challenging concept
por: van der Wiel, Erica, et al.
Publicado: (2017)

Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study
por: Beugeling, Max, et al.
Publicado: (2019)

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2020)

Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson’s disease
por: Luinstra, Marianne, et al.
Publicado: (2019)

The effects of oxygen concentration on cell death, anti-oxidant transcription, acute inflammation, and cell proliferation in precision-cut lung slices
por: Ruigrok, Mitchel J. R., et al.
Publicado: (2019)

Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination
por: Tomar, Jasmine, et al.
Publicado: (2019)

Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems
por: Broesder, Annemarie, et al.
Publicado: (2021)

Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery
por: Broesder, Annemarie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64chc9djqe1694cd6s1ojg3s3t